Vimarsana
Biggest News Aggregation in the World

Page 10 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

Risk Evaluation and Mitigation Strategies [REMS] Program Considerations For Bispecific Therapy - Vimarsana News

Risk Evaluation and Mitigation Strategies [REMS] Program Considerations For Bispecific Therapy

A panel discussion covers considerations within REMS programs aimed at minimizing risks associated with bispecific therapy. NOTE: Not all FDA-approved bispecific antibodies are associated with a REMS protocol.

Source: ajmc.com
Achieving Seamless Care Transitions With Patients Receiving Bispecific Therapy - Vimarsana News

Achieving Seamless Care Transitions With Patients Receiving Bispecific Therapy

Providers delve into considerations for continuation of optimal care when patients receiving bispecific therapy transition between care settings.

Source: ajmc.com
FDA approves 2nd Medtronic neurostimulator - Vimarsana News

FDA approves 2nd Medtronic neurostimulator

Medtronic receives FDA approval for Percept RC neurostimulator with exclusive BrainSense technology, expanding treatment options for movement disorders.;

Caliway Announces FDA Acceptance of CBL-514 IND Application for Placebo-Controlled Phase 2 Study to treat Dercum's Disease - Vimarsana News

Caliway Announces FDA Acceptance of CBL-514 IND Application for Placebo-Controlled Phase 2 Study to treat Dercum's Disease

/PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that the United States Food and Drug Administration (U.S. FDA) has accepted the CBL-514...

FDA approves AstraZeneca and Ionis' treatment for ATTR polyneuropathy - Vimarsana News

FDA approves AstraZeneca and Ionis' treatment for ATTR polyneuropathy

AstraZeneca and Ionis have received FDA approval for Waiuna, their treatment for polyneuropathy in life-threatening disease transthyretin-mediated amyloidosis (ATTR).